Compare · CTVA vs RKDA
CTVA vs RKDA
Side-by-side comparison of Corteva Inc. (CTVA) and Arcadia Biosciences Inc. (RKDA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTVA and RKDA operate in Farming/Seeds/Milling (Consumer Staples), so they compete in similar markets.
- CTVA is the larger of the two at $57.30B, about 38349.8x RKDA ($1.5M).
- Over the past year, CTVA is up 18.0% and RKDA is down 86.1% - CTVA leads by 104.1 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- CTVA has more recent analyst coverage (25 ratings vs 1 for RKDA).
- Company
- Corteva Inc.
- Arcadia Biosciences Inc.
- Price
- $86.27+0.67%
- $0.67-0.80%
- Market cap
- $57.30B
- $1.5M
- 1M return
- +15.88%
- -24.15%
- 1Y return
- +17.98%
- -86.15%
- Industry
- Farming/Seeds/Milling
- Farming/Seeds/Milling
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2015
- News (4w)
- 4
- 4
- Recent ratings
- 25
- 1
Corteva Inc.
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.
Arcadia Biosciences Inc.
Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
Latest CTVA
- Corteva and Arevo Partner on Soy Crop Nutrition
- Corteva Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor
- Corteva Announces Board of Directors for Future Crop Protection Company
- FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
- Amendment: Corteva Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments
- Corteva to Participate in Wolfe's Materials of the Future Conference
- CEO, Crop Protection Business Kissam Luther C Iv was granted 24,138 shares, increasing direct ownership by 2,414% to 25,138 units (SEC Form 4)
- New insider Kissam Luther C Iv claimed ownership of 1,000 shares (SEC Form 3)
- Corteva Announces Dates for Second Quarter 2026 Earnings Release and Webcast
Latest RKDA
- SEC Form EFFECT filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Other Events
- SEC Form D filed by Arcadia Biosciences Inc.
- SEC Form S-3 filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SEC Form 10-Q filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights